Table 3.
Parameters | Evaluations | Placebo (n = 19) | GMCT (n = 19) | ||
---|---|---|---|---|---|
Mean ± SD | p value* | Mean ± SD | p value* | ||
1-RM Bench press (kg) | Baseline | 48.21 ± 8.89 | – | 49.21 ± 9.03 | – |
Day 14 | 49.00 ± 8.60 | 0.1034 | 55.47 ± 8.75 | < 0.0001 | |
Day 28 | 50.42 ± 8.38 | 0.1189 | 68.11 ± 8.82 | < 0.0001 | |
Day 42 | 51.63 ± 8.62 | 0.0471 | 72.68 ± 10.28 | < 0.0001 | |
1-RM Leg press (kg) | Baseline | 67.79 ± 31.36 | – | 73.58 ± 21.33 | – |
Day 14 | 69.00 ± 30.73 | 0.2152 | 82.84 ± 20.79 | < 0.0001 | |
Day 28 | 71.00 ± 30.40 | 0.2134 | 95.11 ± 26.42 | < 0.0001 | |
Day 42 | 73.00 ± 30.14 | 0.0660 | 102.89 ± 25.20 | < 0.0001 | |
No. of maximum repetitions-Leg press | Baseline | 4.26 ± 1.33 | – | 4.16 ± 3.32 | – |
Day 14 | 5.42 ± 1.12 | < 0.0001 | 7.16 ± 2.99 | < 0.0001 | |
Day 28 | 6.05 ± 0.97 | < 0.0001 | 9.26 ± 2.79 | < 0.0001 | |
Day 42 | 6.32 ± 1.11 | < 0.0001 | 10.74 ± 2.56 | < 0.0001 |
*Intragroup comparison between baseline and respective days of evaluation in placebo and GMCT group using t-test (p < 0.05)